High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies. Gervais A, Marchal A, Maillard A, Le Voyer T, et al. Proc Natl Acad Sci U S A 2026;123:e2518581123.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gervais A, Marchal A, Maillard A, Le Voyer T, et al. High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies. Proc Natl Acad Sci U S A 2026;123:e2518581123.
PMID: 42536442